Medplus Health Services Limited Stock Price Today (NSE: MEDPLUS)

Medplus Health Services Limited

656.100.20 (0.03%)
Market Closed

Fundamental Score

...

Medplus Health Services Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Medplus Health Services Limited share price today is 656.10, down 0.03% on NSE/BSE as of 16 September 2026. Medplus Health Services Limited (MEDPLUS) is a Mid-cap company in the Pharmacy Retail sector with a market capitalisation of 7.88K (Cr). The 52-week high for MEDPLUS share price is 1022.20 and the 52-week low is 645.00. At a P/E ratio of 37.41x, MEDPLUS is currently trading below its industry average P/E of 44.45x. The company has a Return on Equity (ROE) of 11.82% and a debt-to-equity ratio of 0.00.

Medplus Health Services Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
701.90
Low
648.00
Volume
1.9L
Change
-2.38%

Medplus Health Services Limited share price chart: -2.38% return over the past month. 52-week high ₹1022.20, 52-week low ₹645.00.

Medplus Health Services Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
656.05660.65645.00656.101.14L (Cr)
660.45666.60654.00656.3061.60K (Cr)
658.00661.45654.00660.1578.31K (Cr)
669.95669.95655.00658.0561.42K (Cr)
664.00677.95660.90669.9572.74K (Cr)
656.00667.00655.80663.4576.13K (Cr)
670.00672.05656.55659.701.51L (Cr)
660.65691.35650.20676.353.11L (Cr)
667.80670.05648.00660.651.90L (Cr)
673.05673.10657.00659.9573.12K (Cr)

Medplus Health Services Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
672.25691.35645.00656.10-2.40%
704.95708.75648.00672.25-4.64%
815.90832.00695.00704.95-13.60%
890.00909.35796.70810.75-8.90%
872.151022.20852.20895.20+2.64%
844.05916.00814.00872.15+3.33%
802.60858.90793.40839.90+4.65%
811.80905.00804.25847.60+4.41%
805.00854.90759.00798.95-0.75%
810.95829.90785.15807.30-0.45%
787.00868.00749.45808.80+2.77%
752.95797.45732.00762.85+1.31%

Returns & Performance

Poor

Return on Equity (ROE)

11.82%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

13.14%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

7.75%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Medplus Health Services Limited Valuation Check

Good

Price to Earnings (P/E)

37.41x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

44.45x

Average P/E of all peers in this sector

Market-cap Classification
Mid-cap
Balance of growth potential and stability.

Shareholding Pattern

Excellent

Promoter Holding

40.29%

% shares held by company founders/management

Good

FII Holding

15.53%

% shares held by foreign institutional investors

Excellent

DII Holding

27.82%

% held by domestic mutual funds, LIC, banks

Poor

Promoter Pledged %

60.74%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-21.68%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

21.84%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

17.56%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-57.75%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

28.65%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.00x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

3.29x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

886.44 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Medplus Health Services Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of MEDPLUS across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Strong Revenue Growth (21.84%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (17.56% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Profit Growth Track Record (28.65% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Healthy Liquidity Position (Current Ratio: 3.20)

Observation: Strong short-term liquidity to meet obligations.

Analysis: Current ratio >1.5 indicates good working capital management.

Strong Cash Generation (₹886.44 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Strong Institutional Confidence (FII+DII: 43.35%)

Observation: Significant professional investor participation.

Analysis: High institutional holding often signals thorough due diligence.

Risk Factors

4 factors identified

Profit Decline Concern (-21.68%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Weak Earnings Growth (-57.75% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

High Share Pledging Risk (60.74%)

Observation: Significant promoter share pledging creates potential overhang.

Analysis: High pledging levels may create selling pressure during market downturns.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Medplus Health Services Limited vs Pharmacy Retail Peers

Peer Comparison - Pharmacy Retail

Compare Medplus Health Services Limited with 1 other companies in the same sector

2 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
38.4/100
656
₹7882.06
37.4
Average
11.82%
Average
13.14%
Average
0.0
Excellent
28.65%
Excellent
17.56%
Excellent
0.00%
55/100
1789
₹7785.39
62.1
Average
6.74%
Poor
12.08%
Average
0.3
Excellent
57.46%
Excellent
30.03%
Excellent
0.00%

Medplus Health Services Limited PE Ratio History

Historical price-to-earnings ratio for MEDPLUS — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 202512.52₹807.3064.5x
FY 20245.45₹830.85152.4x
FY 20234.17₹750.75180x
FY 20228.52₹613.6072x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Medplus Health Services Limited Quarterly Performance

Latest quarterly metrics for MEDPLUS — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

21.84%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-21.68%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

17.56%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

28.65%

Compounded annual net profit growth over 5 years

Medplus Health Services Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for MEDPLUS — calculated from daily price history

55RSI 14
Neutral — RSI 55

Momentum is balanced — neither overbought nor oversold.

SMA 50
724
▼ Price below SMA 50 — Short-term bearish
SMA 200
813
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
193K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Medplus Health Services Limited Financial Statements

Annual income statement, balance sheet and cash flow for Medplus Health Services Limited (MEDPLUS) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Medplus Health Services Limited

Loading latest quarterly results...

About MEDPLUS (Medplus Health Services Limited)

Medplus Health Services Ltd is a ubiquitous presence in the Indian pharmacy retail landscape, distinguished by its extensive network of strategically located stores. More than just... a place to purchase medication, Medplus offers a comprehensive healthcare destination. Shelves are stocked with an array of pharmaceuticals, ranging from essential prescription drugs to readily available over-the-counter remedies. Beyond traditional medicines, Medplus caters to a growing health-conscious consumer base by providing a wide selection of wellness products, including vitamins, nutritional supplements, and medical devices designed for home use. This commitment to diverse product offerings positions Medplus as a one-stop shop for individuals seeking both curative and preventative healthcare solutions. The reach of Medplus extends beyond prescription fulfillment and over-the-counter sales. The company has diversified its offerings to include fast-moving consumer goods, recognizing the convenience and value of integrating everyday household essentials into its retail environment. Customers can find a variety of personal care items, such as toiletries, soaps, and sanitizers, alongside baby care products and cleaning supplies. This strategic inclusion of FMCG items enhances the shopping experience, making Medplus a convenient location for customers to address multiple needs in a single trip. The company's commitment to quality and value ensures that customers have access to reliable and affordable products across all categories. Beyond its retail presence, Medplus operates a wholesale division, catering to smaller pharmacies and healthcare providers through a cash-and-carry model. This business segment contributes to the broader accessibility of pharmaceuticals and healthcare products across the Indian market. In addition to product sales, Medplus also offers diagnostic services, further solidifying its position as a comprehensive healthcare provider. This multifaceted approach, encompassing retail, wholesale, and diagnostic services, sets Medplus apart in the competitive pharmacy retail sector, offering a holistic approach to meeting the diverse healthcare needs of its customers.

Company Details

Symbol:MEDPLUS
Industry:Pharmacy Retail
Sector:Pharmacy Retail

Key Leadership

Dr. Gangadi Madhukar Reddy
Founder, CEO, MD & Chairman
Mr. Sujit Kumar Mahato
Chief Financial Officer
Dr. Cherukupalli Bhaskar Reddy
COO & Whole Time Director

MEDPLUS Share Price: Frequently Asked Questions

What is the current share price of Medplus Health Services Limited?

Medplus Health Services Limited (MEDPLUS) trades at ₹656.10 on NSE and BSE. Market cap ₹7.88K (Cr). Educational data only.

What is the P/E ratio of Medplus Health Services Limited?

Medplus Health Services Limited has a P/E of 37.41x vs industry average 44.45x.

What is the Bull Run score for Medplus Health Services Limited?

Medplus Health Services Limited has a Bull Run score of 38.4/100 based on 25+ financial parameters.

Does Medplus Health Services Limited pay dividends?

Medplus Health Services Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Medplus Health Services Limited?

Medplus Health Services Limited has ROE of 11.82%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Medplus Health Services Limited?

Medplus Health Services Limited has debt-to-equity of 0.00.

Is Medplus Health Services Limited a good investment?

Bull Run gives Medplus Health Services Limited a score of 38.4/100. This is not investment advice — consult a SEBI-registered advisor.